Bystolic - 2007 FDA approvals

Getting the most out of First-in-Human and Early Clinical Trials
In a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected Devices
After launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
Special Studies in Cancer Patients: AME and Cardiac Safety
FierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine Act
Beginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ

January 22, 2008 — 3:03pm ET | By Maureen Martino

Tools

Drug: Bystolic (nebivolol)
Indication: Hypertension
Company: Forest Laboratories and Mylan
Approval Date: Decembe 18, 2007

Scoop: Bystolic is theÂ 19th approved beta blockerÂ available in the U.S. The drug's developers say it has "placebo-like" side effects, making compliance easier for patients with high blood pressure.

More News:
New "me-too" beta blocker dissed by experts. Report

SHARE
WITH:

Most Popular Stories

Webinars

Featured Jobs

Events

Bystolic - 2007 FDA approvals

THE FIERCEMARKETS NETWORK